Holland Capital has invested in Gullimex to support its ambition of becoming a leading European provider of measurement and quality control solutions in the food and medical sectors.

Information on the Target

Gullimex, established in 1981, is a prominent player in the field of measurement, quality, and control solutions within the food and medical sectors. With a dedicated team of over 60 experts, the company supports a diverse clientele by enhancing food safety, patient safety, and hygiene through innovative measuring and recording methods. Gullimex operates offices in the Netherlands, Belgium, and Germany, ensuring a strong presence in key European markets and a commitment to delivering optimal standards in safety and quality.

The company's integrated approach combines hardware, software, and services, allowing it to become a comprehensive partner that understands the specific requirements and challenges of its clients in the food and medical industries. Gullimex's mission is to provide consistent quality measurements, ensure optimal hygiene, and foster safe production processes within critical business operations.

Industry Overview in the Target’s Specific Country

The importance of food safety, patient safety, and hygiene continues to escalate in the Netherlands and across Europe, driven by evolving regulations and increasing expectations for quality and efficiency. As consumer aware

View Source

Similar Deals

819 Capital Partners RiverD International

2026

Growth Equity & Expansion Capital Bio Diagnostics & Testing Netherlands
Elevating Capital Healthplus.ai

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Netherlands
TFH Holland Salders

2024

Growth Equity & Expansion Capital Ambulance & Emergency Services Netherlands
Health Investment Partners Dytter

2023

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Netherlands
Craft Capital Cleanroom Combination Group

2023

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Netherlands
Social IV TheSocialMedwork

2023

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Netherlands

Holland Capital

invested in

Gullimex

in 2025

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert